31 May 2017

From Thursday, 1st June, 2017, all patients in the USA requiring deflazacort should contact the EMFLAZA CaresTM program on 1-844-EMFLAZA (1-844-363-5292). EMFLAZATM (deflazacort) is indicated for the treatment of Duchenne Muscular Dystrophy in patients of 5 years old and older, and a member of the EMFLAZA CaresTM team will be able to help you access the product, and provide details of the EMFLAZATM Bridge Program through which EMFLAZATM (deflazacort) may be available to you free of charge for a limited period of time.

Further information about EMFLAZATM (deflazacort) and product access is also available online: www.EMFLAZA.com

Wednesday 31 May 2017

From Thursday, 1st June, 2017, all patients in the USA requiring deflazacort should contact the EMFLAZA CaresTM program on 1-844-EMFLAZA...

Wednesday 18 January 2017

Masters Speciality Pharma is pleased to announce its appointment as Amgen (Europe) GmbH’s exclusive supplier.